LLY compared with MCRB: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

MCRBSeres Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

MCRBSeres Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

MCRB2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±32.5%▲+6.63%×0.20

Q2 FY26±41.0%▼−4.67%×0.11

= impliedLLY realized, solidMCRB realized, hatchedOne scale, both sides: full bar = 42%× = |realized| ÷ impliedspan: LLY 267d · MCRB 91dSource: market data

LLYELI Lilly & Co

1,413.42▲+4.39%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

MCRBSeres Therapeutics, Inc.

1.71▼−13.64%

Regular sessionNov 9 '26

Mkt cap$20.2MRevenue$593,000Q3 FY26Revenue—

Compare

Regular sessionNov 9 '26

LLYELI Lilly & Co

MCRBSeres Therapeutics, Inc.

1,413.42▲+4.39%

Price

1.71▼−13.64%

$1.2T

Mkt cap

$20.2M

Q3 FY26$24.4B

Revenue

$593,000Q3 FY26

FY25$65.2B

Revenue

—

LLY1,413.42▲+4.39%vsMCRB1.71▼−13.64%Regular sessionNov 9 '26